Related Experiment Video
Updated: Feb 17, 2026

Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach
Published on: October 18, 2024
Outcomes in coronary artery disease patients with sleepy obstructive sleep apnoea on CPAP
Yüksel Peker1,2, Erik Thunström2,3, Helena Glantz4
1Dept of Pulmonary Medicine, Faculty of Medicine, Marmara University, Istanbul, Turkey yuksel.peker@marmara.edu.tr.
Insights
Coronary artery disease patients with treated obstructive sleep apnea showed no increased risk for major adverse cardiovascular events compared to those without sleep apnea, suggesting CPAP treatment is effective.
Area of Science:
- Cardiology
- Sleep Medicine
- Clinical Research
Background:
- Patients with coronary artery disease (CAD) and obstructive sleep apnea (OSA) face higher risks of major adverse cardiovascular and cerebrovascular events (MACCEs).
- The impact of continuous positive airway pressure (CPAP) treatment on these risks in OSA patients with CAD is not fully understood.
Purpose of the Study:
- To determine if the risk of MACCEs is similar between CAD patients with treated OSA and CAD patients without OSA.
- To evaluate the effectiveness of CPAP therapy in mitigating cardiovascular risks associated with OSA in CAD patients.
Main Methods:
- An observational study involving revascularised CAD patients with OSA (apnea-hypopnea index ≥15) and daytime sleepiness, offered CPAP treatment (n=155).
- A control group of CAD patients without OSA (apnea-hypopnea index <5) (n=112) was included.
- Primary endpoint was the first MACCE event, with a median follow-up of 57 months.
Main Results:
- The incidence of MACCEs was 23.2% in the OSA group versus 16.1% in the no-OSA group (adjusted hazard ratio 0.96, p=0.923).
- Age and prior revascularization were associated with increased MACCE risk.
- Coronary artery bypass grafting at baseline was linked to a reduced risk of MACCEs.
Conclusions:
- The risk for MACCEs was not significantly increased in CAD patients with symptomatic OSA receiving CPAP treatment compared to those without OSA.
- CPAP therapy appears to normalize the cardiovascular risk profile in CAD patients with OSA, bringing it closer to that of patients without OSA.
Abstract:
Coronary artery disease (CAD) patients with obstructive sleep apnoea (OSA) have increased risk for major adverse cardiovascular and cerebrovascular events (MACCEs) compared with CAD patients without OSA. We aimed to address if the risk is similar in both groups when OSA patients are treated.This study was a parallel observational arm of the RICCADSA randomised controlled trial, conducted in Sweden between 2005 and 2013. Patients with revascularised CAD and OSA (apnoea-hypopnoea index (AHI) ≥15 events·h-1) with daytime sleepiness (Epworth Sleepiness Scale score ≥10) were offered continuous positive airway pressure (CPAP) (n=155); CAD patients with no OSA (AHI <5 events·h-1) acted as controls (n=112), as a randomisation of sleepy OSA patients to no treatment would not be ethically feasible. The primary end-point was the first event of MACCEs. Median follow-up was 57 months.The incidence of MACCEs was 23.2% in OSA patients versus 16.1% in those with no OSA (adjusted hazard ratio 0.96, 95% CI 0.40-2.31; p=0.923). Age and previous revascularisation were associated with increased risk for MACCEs, whereas coronary artery bypass grafting at baseline was associated with reduced risk.We conclude that the risk for MACCEs was not increased in CAD patients with sleepy OSA on CPAP compared with patients without OSA.
More Related Videos
Related Concept Videos
Sleep Apnea
The condition is more prevalent among...
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
COPD: Management Using Bronchodilators and Corticosteroids
Heart Failure VI: Adjunct Therapies
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Hyperpnea and Hyperventilation

